Home > Boards > US Listed > Medical - Healthcare > Gilead Sciences, Inc. (GILD)

Let me ask you, why do you think

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
fung_derf Member Profile
Member Level 
Followed By 222
Posts 110,508
Boards Moderated 21
Alias Born 08/30/01
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/25/2020 5:05:20 PM
European Commission Grants Marketing Authorization for Jyseleca® ▼ (Filgotinib) for the Treatment of Adults With Moderate ... Business Wire - 9/25/2020 1:00:00 PM
Jyseleca® (Filgotinib) Approved in Japan for Rheumatoid Arthritis Business Wire - 9/25/2020 2:00:00 AM
Gilead Sciences Prices $7.25 Billion of Senior Unsecured Notes Business Wire - 9/23/2020 10:33:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/23/2020 9:10:48 AM
Gilead's Magrolimab Gets FDA Breakthrough Therapy Designation in Myelodysplastic Syndrome Dow Jones News - 9/15/2020 8:54:00 AM
Gilead’s Magrolimab, an Investigational Anti-CD47 Monoclonal Antibody, Receives FDA Breakthrough Therapy Designation for Tr... Business Wire - 9/15/2020 8:00:00 AM
Hospitalized Covid-19 Patients Recovered Faster With Arthritis Drug Dow Jones News - 9/14/2020 11:26:00 AM
Immunomedics Shares More Than Double After Gilead Deal Dow Jones News - 9/14/2020 8:26:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2020 8:02:48 AM
Gilead Acquires Cancer-Drug Maker -- WSJ Dow Jones News - 9/14/2020 3:02:00 AM
Gilead Reaches Deal to Buy Immunomedics for $21 Billion -- 5th Update Dow Jones News - 9/13/2020 9:01:00 PM
Gilead Reaches Deal to Buy Immunomedics for $21 Billion--4th Update Dow Jones News - 9/13/2020 4:29:00 PM
Gilead Sciences to Acquire Immunomedics Business Wire - 9/13/2020 3:00:00 PM
Gilead Nears Deal to Buy Immunomedics for More Than $20 Billion--3rd Update Dow Jones News - 9/12/2020 4:01:00 PM
Gilead Nears Deal to Buy Immunomedics for More Than $20 Billion--2nd Update Dow Jones News - 9/12/2020 3:50:00 PM
Gilead Nears Deal to Buy Immunomedics for More Than $20 Billion--Update Dow Jones News - 9/12/2020 3:39:00 PM
Gilead Nears Deal to Buy Immunomedics for More Than $20 Billion Dow Jones News - 9/12/2020 3:22:00 PM
Kite Submits Supplemental Biologics License Application to U.S. Food & Drug Administration for Yescarta® in Relapsed or Refr... Business Wire - 9/4/2020 8:30:00 AM
Gilead's Kite Forms AML Collaboration With HiFiBiO Therapeutics Dow Jones News - 9/3/2020 8:56:00 AM
Kite and HiFiBiO Therapeutics Partner to Discover Novel Targets and Antibodies Against Acute Myeloid Leukemia Business Wire - 9/3/2020 8:00:00 AM
Jounce Therapeutics Shares Up 54% After License Agreement With Gilead Dow Jones News - 9/1/2020 10:21:00 AM
Gilead, Jounce In License Agreement for Immunotherapy Program Dow Jones News - 9/1/2020 9:19:00 AM
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program GlobeNewswire Inc. - 9/1/2020 8:30:10 AM
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program Business Wire - 9/1/2020 8:30:00 AM
fung_derf Member Level  Tuesday, 05/19/20 03:15:17 PM
Re: I_luv_cydy post# 3878
Post # of 4382 
Let me ask you, why do you think the stock went up in price so quickly and drastically?

Buy on the way up!!! Just my opinion, of course.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences